Drug therapy - Schizophrenia

被引：277

作者：

Kane, JM ^{[1
]}

机构：

[1] ALBERT EINSTEIN COLL MED, DEPT PSYCHIAT, BRONX, NY USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1996年 / 334卷 / 01期

关键词：

D O I：

10.1056/NEJM199601043340109

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：34 / 41

页数：8

共 101 条

[1] CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES [J].

ALVIR, JMJ ;

LIEBERMAN, JA ;

SAFFERMAN, AZ ;

SCHWIMMER, JL ;

SCHAAF, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :162-167

[2] RECEPTOR ACTIVITY AND TURNOVER OF DOPAMINE AND NORADRENALINE AFTER NEUROLEPTICS [J].

ANDEN, NE ;

BUTCHER, SG ;

CORRODI, H ;

FUXE, K ;

UNGERSTEDT, U .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 11 (03) :303-+

[3]

[Anonymous], PSYCHIAT HOSP

[4]

ARANA GW, 1986, PSYCHOPHARMACOL BULL, V22, P77

[5]

BAKER RW, 1992, J CLIN PSYCHIAT, V53, P439

[6]

BARBEE JG, 1992, AM J PSYCHIAT, V149, P1129

[7]

BARBEE JG, 1992, AM J PSYCHIAT, V149, P506

[8] HIGH DOSAGE HALOPERIDOL THERAPY IN CHRONIC-SCHIZOPHRENIC PATIENTS - DOUBLE-BLIND-STUDY OF CLINICAL-RESPONSE, SIDE-EFFECTS, SERUM HALOPERIDOL, AND SERUM PROLACTIN [J].

BJORNDAL, N ;

BJERRE, M ;

GERLACH, J ;

KRISTJANSEN, P ;

MAGELUND, G ;

OESTRICH, IH ;

WAEHRENS, J .

PSYCHOPHARMACOLOGY, 1980, 67 (01) :17-23

[9]

BORISON RL, 1992, PSYCHOPHARMACOL BULL, V28, P213

[10]

CARMAN JS, 1981, J CLIN PSYCHIAT, V42, P124

← 1 2 3 4 5 6 7 8 9 10 →